Cecilia Jimenez-Moreno
Overview
Explore the profile of Cecilia Jimenez-Moreno including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
142
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Marsh K, Gonzalez Sepulveda J, Berlin C, Levitan B, Boeri M, Groothuis-Oudshoorn C, et al.
Patient
. 2025 Jan;
18(2):101-108.
PMID: 39873903
Using patient preference information (PPI) to incorporate patient voices into the drug development lifecycle can help align therapies with the needs and values of patients. However, several barriers have limited...
2.
Pinto C, Tervonen T, Jimenez-Moreno C, Levitan B, Soriano Gabarro M, Girman C, et al.
Patient
. 2023 Dec;
17(2):147-159.
PMID: 38085458
Objectives: To understand industry practices and challenges when submitting patient experience data (PED) for regulatory decisions by the US Food and Drug Administration (FDA). Methods: A two-part online survey related...
3.
Soekhai V, Donkers B, Johansson J, Jimenez-Moreno C, Pinto C, de Wit G, et al.
Patient
. 2023 Feb;
16(3):239-253.
PMID: 36781628
Background And Objectives: Case 2 best-worst scaling (BWS-2) is an increasingly popular method to elicit patient preferences. Because BWS-2 potentially has a lower cognitive burden compared with discrete choice experiments,...
4.
Heidenreich S, Finney Rutten L, Miller-Wilson L, Jimenez-Moreno C, Chua G, Fisher D
Cancer Med
. 2022 Mar;
11(16):3156-3167.
PMID: 35315224
Background: Guidelines include several options for average-risk colorectal cancer (CRC) screening that vary in aspects such as invasiveness, recommended frequency, and precision. Thus, patient and provider preferences can help identify...
5.
Stefanetti R, Blain A, Jimenez-Moreno C, Errington L, Ng Y, McFarland R, et al.
Wellcome Open Res
. 2020 Jul;
5:84.
PMID: 32671231
The benefit and safety of exercise training for patients with neuromuscular disorders (NMDs) has long been a contentious topic. This is, in part, due to recognised challenges associated with rare...
6.
Landfeldt E, Nikolenko N, Jimenez-Moreno C, Cumming S, Monckton D, Faber C, et al.
J Neurol
. 2020 Jun;
267(11):3235-3242.
PMID: 32542526
Objective: The objective of this longitudinal, observational study was to investigate change over time in ability to perform activities of daily living in myotonic dystrophy type 1 (DM1). Methods: Adults...
7.
Landfeldt E, Nikolenko N, Jimenez-Moreno C, Cumming S, Monckton D, Faber C, et al.
Acta Neurol Scand
. 2020 Jan;
141(5):380-387.
PMID: 31889295
Objectives: The objective of this cross-sectional, observational study was to investigate performance of activities of daily living in patients with myotonic dystrophy type 1 (DM1). Materials And Methods: Adults with...
8.
Cumming S, Jimenez-Moreno C, Okkersen K, Wenninger S, Daidj F, Hogarth F, et al.
Neurology
. 2019 Aug;
93(10):e995-e1009.
PMID: 31395669
Objective: To evaluate the role of genetic variation at the locus on symptomatic diversity in 250 adult, ambulant patients with myotonic dystrophy type 1 (DM1) recruited to the Observational Prolonged...
9.
Landfeldt E, Nikolenko N, Jimenez-Moreno C, Cumming S, Monckton D, Gorman G, et al.
J Neurol
. 2019 Feb;
266(4):998-1006.
PMID: 30788616
Objective: The objective of this cross-sectional, observational study was to investigate the disease burden of myotonic dystrophy type 1 (DM1), a disabling muscle disorder. Methods: Adults with DM1 were recruited...
10.
Landfeldt E, Edstrom J, Jimenez-Moreno C, van Engelen B, Kirschner J, Lochmuller H
Patient
. 2019 Feb;
12(4):365-373.
PMID: 30714084
Background: Adult-onset myotonic dystrophy type 1 (DM1) is a chronic, multisystem disorder that leads to disability and premature death. Objectives: The objective of our study was to conduct a systematic...